Moderna, Inc.
MRNA
$25.18
$1.124.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -57.47% | -39.64% | -39.56% | -53.40% | -43.18% |
| Total Other Revenue | 3.42% | -19.46% | 4.20% | -28.25% | -69.53% |
| Total Revenue | -56.07% | -39.05% | -38.35% | -52.75% | -44.29% |
| Cost of Revenue | -27.82% | -48.86% | -46.14% | -48.22% | -47.61% |
| Gross Profit | -404.52% | 64.45% | 57.22% | 36.69% | 72.58% |
| SG&A Expenses | -17.94% | -26.13% | -26.75% | -24.21% | -11.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.74% | -34.42% | -32.90% | -35.23% | -34.04% |
| Operating Income | -28.59% | 29.39% | 27.44% | 6.94% | -1.05% |
| Income Before Tax | -34.00% | 32.02% | 29.07% | 8.50% | 0.17% |
| Income Tax Expenses | 71.32% | -102.74% | -104.20% | -105.96% | -111.63% |
| Earnings from Continuing Operations | -40.11% | 50.52% | 43.75% | 24.46% | 35.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.11% | 50.52% | 43.75% | 24.46% | 35.83% |
| EBIT | -28.59% | 29.39% | 27.44% | 6.94% | -1.05% |
| EBITDA | -37.81% | 25.37% | 22.43% | -3.81% | -9.05% |
| EPS Basic | -38.95% | 51.08% | 44.29% | 25.00% | 36.51% |
| Normalized Basic EPS | -36.35% | 31.77% | 29.98% | 8.80% | 2.04% |
| EPS Diluted | -38.37% | 51.08% | 44.31% | 25.16% | 37.42% |
| Normalized Diluted EPS | -36.10% | 31.79% | 30.00% | 8.55% | 4.67% |
| Average Basic Shares Outstanding | 1.11% | 1.05% | 0.98% | 0.46% | -0.07% |
| Average Diluted Shares Outstanding | -0.71% | 1.04% | 0.97% | -0.77% | -0.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |